Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1351 to 1400 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
676\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 19 kda polypeptide (ec 2.7.7.6) (rpb7). [source:swissprot;acc:p52433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.469\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
245.613\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05654\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein p0-like protein; 60s acidic ribosomal protein po; ribosomal protein, large, p0-like. [source:refseq;acc:nm\_016183]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
245.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
257.636\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.796\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
677\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fibrillarin (34 kda nucleolar scleroderma antigen). [source:swissprot;acc:p22087]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
245.246\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.483\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.763\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm4 (glycine-rich protein) (grp). [source:swissprot;acc:q9y4z0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.944\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.745\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05628\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
678\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidylprolyl isomerase-like 4; cyclophilin-type peptidyl-prolyl cis-trans isomerase; ppiase; serologically defined breast cancer antigen ny-br-18. [source:refseq;acc:nm\_139126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.135\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.405\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.73\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.175\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05609\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
679\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.175\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.693\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
680\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sr rich protein. [source:refseq;acc:nm\_032870]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.293\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.653\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
681\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c5 (hox-3d) (cp11). [source:swissprot;acc:q00444]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.593\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.987\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.606\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
682\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c6 (hox-3c) (hho.c8) (cp25). [source:swissprot;acc:p09630]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
upf0202 protein kiaa1709. [source:swissprot;acc:q9h0a0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
246.055\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.458\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.597\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
683\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-d4 (hox-4b) (hox-5.1) (hho.c13). [source:swissprot;acc:p09016]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
osteoclast stimulating factor 1. [source:swissprot;acc:q92882]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.809\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
243.289\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.48\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
684\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b5 (hox-2a) (hho.c10) (hu-1). [source:swissprot;acc:p09067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoribosylformylglycinamidine synthase (ec 6.3.5.3) (fgam synthase) (fgams) (formylglycinamide ribotide amidotransferase) (fgarat) (formylglycinamide ribotide synthetase). [source:swissprot;acc:o15067]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
235.027\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
11.447\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
685\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional purine biosynthesis protein purh [includes: phosphoribosylaminoimidazolecarboxamide formyltransferase (ec 2.1.2.3) (aicar transformylase); imp cyclohydrolase (ec 3.5.4.10) (inosinicase) (imp synthetase) (atic)]. [source:swissprot;acc:p31939]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a5 (hox-1c). [source:swissprot;acc:p20719]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
686\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a4 (hox-1d) (hox-1.4). [source:swissprot;acc:q00056]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
multifunctional protein ade2 [includes: phosphoribosylaminoimidazole- succinocarboxamide synthase (ec 6.3.2.6) (saicar synthetase); phosphoribosylaminoimidazole carboxylase (ec 4.1.1.21) (air carboxylase) (airc)]. [source:swissprot;acc:p22234]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.027\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.447\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
687\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dendritic cell protein. [source:refseq;acc:nm\_006360]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
223.121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.685\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.436\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinal short-chain dehydrogenase/reductase 3. [source:refseq;acc:nm\_016246]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
688\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 16 kda polypeptide (ec 2.7.7.6) (rpb4). [source:swissprot;acc:o15514]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
237.554\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
250.823\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05586\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potential carboxypeptidase-like protein x2 precursor. [source:swissprot;acc:q8n436]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.121\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
211.685\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
11.436\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
689\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase n catalytic chain precursor (ec 3.4.17.3) (arginine carboxypeptidase) (kininase 1) (serum carboxypeptidase n) (scpn) (anaphylatoxin inactivator) (plasma carboxypeptidase b). [source:swissprot;acc:p15169]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, alpha subunit (tcp-1-alpha) (cct-alpha). [source:swissprot;acc:p17987]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
135.379\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
128.225\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05579\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
690\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cpz gene product. [source:refseq;acc:nm\_003652]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.685\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.436\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.593\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.987\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05553\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
691\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
217.602\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.195\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05532\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase h precursor (ec 3.4.17.10) (cph) (carboxypeptidase e) (cpe) (enkephalin convertase) (prohormone processing carboxypeptidase). [source:swissprot;acc:p16870]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.685\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.436\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
692\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.602\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.195\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05532\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potential carboxypeptidase x precursor (ec 3.4.17.-) (metallocarboxypeptidase cpx-1). [source:swissprot;acc:q96sm3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.685\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.436\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
693\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
217.602\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.195\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.407\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein nova-1 (neuro-oncological ventral antigen 1) (onconeural ventral antigen-1) (paraneoplastic ri antigen) (ventral neuron-specific protein 1). [source:swissprot;acc:p51513]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.554\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.847\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05524\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
694\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.602\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.195\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.407\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon, catalytic subunit a (ec 2.7.7.7) (dna polymerase ii subunit a). [source:swissprot;acc:q07864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.907\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
229.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05475\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
695\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleotide-binding protein 1 (nbp 1). [source:swissprot;acc:p53384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.739\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.398\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.341\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peptidylprolyl isomerase-like 4; cyclophilin-type peptidyl-prolyl cis-trans isomerase; ppiase; serologically defined breast cancer antigen ny-br-18. [source:refseq;acc:nm\_139126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.135\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.405\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05471\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
696\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleotide binding protein 2 (nbp 2). [source:swissprot;acc:q9y5y2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.739\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.398\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.341\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sr rich protein. [source:refseq;acc:nm\_032870]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.293\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05455\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
697\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
ferritin heavy chain (ferritin h subunit). [source:swissprot;acc:p02794]\vspace{3pt}}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.444\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.113\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05419\vspace{3pt}}\\\cline{3-3}\cline{6-6}
&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
11.331\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
698\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cellular repressor of e1a-stimulated genes 2. [source:refseq;acc:nm\_153836]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
220.438\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.118\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.32\vspace{3pt}}\\\cline{2-4}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ferritin; ferritin heavy chain-like; ferritin h subunit. [source:refseq;acc:nm\_177478]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.437\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05413\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
699\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cellular repressor of e1a-stimulated genes 2. [source:refseq;acc:nm\_153836]\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.438\vspace{3pt}}}&&\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj681n20.2 (novel protein similar to ferritin, light polypeptide (ftl)). [source:sptrembl;acc:q9byw6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
11.32\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
700\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
disks large-associated protein 1 (dap-1) (guanylate kinase-associated protein) (hgkap) (sap90/psd-95-associated protein 1) (sapap1) (psd- 95/sap90 binding protein 1). [source:swissprot;acc:o14490]\vspace{3pt}}&&&&\\\cline{2-3}\cline{6-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj681n20.2 (novel protein similar to ferritin, light polypeptide (ftl)). [source:sptrembl;acc:q9byw6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1.05413\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/